Home LiteratureArticle Details
PMID: 12138198 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

RIP2, a checkpoint in myogenic differentiation.

Molecular and cellular biology ·Vol. 22 ·No. 16 ·2002-08-00 ·Pages 5879-86

Munz B, Hildt E, Springer ML, Blau HM

Abstract

Using a subtractive cDNA library hybridization approach, we found that receptor interacting protein 2 (RIP2), a tumor necrosis factor receptor 1 (TNFR-1)-associated factor, is a novel early-acting gene that decreases markedly in expression during myogenic differentiation. RIP2 consists of three domains: an amino-terminal kinase domain, an intermediate domain, and a carboxy-terminal caspase activation and recruitment domain (CARD). In some cell types, RIP2 has been shown to be a potent inducer of apoptosis and an activator of NF-kappa B. To analyze the function of RIP2 during differentiation, we transduced C2C12 myoblasts with retroviral vectors to constitutively produce RIP2 at high levels. When cultured in growth medium, these cells did not show an enhanced rate of proliferation compared to controls. When switched to differentiation medium, however, they continued to proliferate, whereas control cells withdrew from the cell cycle, showed increased expression of differentiation markers such as myogenin, and began to differentiate into multinucleated myotubes. The complete RIP2 protein appeared to be necessary to inhibit myogenic differentiation, since two different deletion mutants lacking either the amino-terminal kinase domain or the carboxy-terminal CARD had no effect. A mutant deficient in kinase activity, however, had effects similar to wild-type RIP2, indicating that phosphorylation was not essential to the function of RIP2. Furthermore, RIP proteins appeared to be important during myogenic differentiation in vivo, as we detected a marked decrease in expression of the RIP2 homolog RIP in several muscle tissues of the dystrophic mdx mouse, a model for continuous muscle degeneration and regeneration. We conclude that RIP proteins can act independently of TNFR-1 stimulation by ligand to modulate downstream signaling pathways, such as activation of NF-kappa B. These results implicate RIP2 in a previously unrecognized role: a checkpoint for myogenic proliferation and differentiation.

MeSH Terms
Animals Apoptosis/physiology Cell Differentiation/physiology Cells, Cultured Humans Mice Mice, Inbred C3H Mice, Inbred C57BL Mice, Inbred mdx Muscle Development/physiology Muscle, Skeletal/cytology,physiology NF-kappa B/metabolism Protein Serine-Threonine Kinases/genetics,metabolism Receptor-Interacting Protein Serine-Threonine Kinase 2 Receptor-Interacting Protein Serine-Threonine Kinases Retroviridae/genetics,metabolism Transduction, Genetic
Chemicals
NF-kappa B Protein Serine-Threonine Kinases RIPK2 protein, human Receptor-Interacting Protein Serine-Threonine Kinase 2 Receptor-Interacting Protein Serine-Threonine Kinases Ripk2 protein, mouse
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Munz Barbara
Baxter Laboratory for Genetic Pharmacology, Stanford University Medical Center, Stanford, California 94305-5175, USA.
Hildt Eberhard
Springer Matthew L
Blau Helen M
References (35)
35 references, click to expand
  1. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.
    Oncogene. 1999 Nov 22;18(49):6867-74 PMID: 10602462
  2. Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-kappaB.
    Mol Cell Biol. 1999 Oct;19(10):6500-8 PMID: 10490590
  3. The RIP-like kinase, RIP3, induces apoptosis and NF-kappaB nuclear translocation and localizes to mitochondria.
    FEBS Lett. 2000 May 19;473(3):285-91 PMID: 10818227
  4. Activated Raf inhibits myogenesis through a mechanism independent of activator protein 1-mediated myoblast transformation.
    J Biol Chem. 2000 Sep 1;275(35):27481-7 PMID: 10867013
  5. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.
    Science. 2000 Sep 29;289(5488):2363-6 PMID: 11009425
  6. Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism.
    J Cell Sci. 2000 Dec;113 Pt 23:4211-20 PMID: 11069766
  7. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion.
    J Cell Physiol. 2001 Jan;186(1):104-15 PMID: 11147804
  8. Elevated p21 mRNA level in skeletal muscle of DMD patients and mdx mice indicates either an exhausted satellite cell pool or a higher p21 expression in dystrophin-deficient cells per se.
    J Mol Med (Berl). 2000;78(10):569-74 PMID: 11199330
  9. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
    Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 PMID: 6828386
  10. Developmental progression of myosin gene expression in cultured muscle cells.
    Cell. 1986 Sep 26;46(7):1075-81 PMID: 3530499
  11. Tumor necrosis factor inhibits human myogenesis in vitro.
    Mol Cell Biol. 1988 Jun;8(6):2295-301 PMID: 3405207
  12. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.
    Nucleic Acids Res. 1990 Jun 25;18(12):3587-96 PMID: 2194165
  13. Acidic fibroblast growth factor (aFGF) in developing normal and dystrophic (mdx) mouse muscles. Distribution in degenerating and regenerating mdx myofibres.
    Growth Factors. 1992;7(2):97-106 PMID: 1384586
  14. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.
    J Cell Biol. 1994 Jun;125(6):1275-87 PMID: 8207057
  15. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death.
    Cell. 1995 May 19;81(4):513-23 PMID: 7538908
  16. RIP2 is a Raf1-activated mitogen-activated protein kinase kinase.
    J Biol Chem. 1999 Nov 19;274(47):33684-90 PMID: 10559258
  17. Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse.
    Biochim Biophys Acta. 2000 Jan 3;1500(1):17-30 PMID: 10564714
  18. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.
    Immunity. 1996 Apr;4(4):387-96 PMID: 8612133
  19. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis.
    J Biol Chem. 1996 Mar 1;271(9):4961-5 PMID: 8617770
  20. Defining the regulatory networks for muscle development.
    Curr Opin Genet Dev. 1996 Aug;6(4):445-53 PMID: 8791524
  21. Skeletal muscle determination and differentiation: story of a core regulatory network and its context.
    Curr Opin Cell Biol. 1996 Dec;8(6):877-89 PMID: 8939680
  22. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis.
    EMBO J. 1996 Nov 15;15(22):6189-96 PMID: 8947041
  23. RAIDD is a new 'death' adaptor molecule.
    Nature. 1997 Jan 2;385(6611):86-9 PMID: 8985253
  24. High-efficiency retroviral infection of primary myoblasts.
    Somat Cell Mol Genet. 1997 May;23(3):203-9 PMID: 9330631
  25. Muscle determination: another key player in myogenesis?
    Curr Biol. 1997 Oct 1;7(10):R620-3 PMID: 9368741
  26. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal.
    Immunity. 1998 Mar;8(3):297-303 PMID: 9529147
  27. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis.
    J Biol Chem. 1998 May 15;273(20):12296-300 PMID: 9575181
  28. RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase.
    J Biol Chem. 1998 Jul 3;273(27):16968-75 PMID: 9642260
  29. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1.
    Curr Biol. 1998 Jul 16;8(15):885-8 PMID: 9705938
  30. Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells.
    Blood. 1999 Jan 15;93(2):617-23 PMID: 9885224
  31. Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts.
    Horm Metab Res. 1999 Feb-Mar;31(2-3):55-64 PMID: 10226782
  32. Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB.
    Curr Biol. 1999 May 20;9(10):539-42 PMID: 10339433
  33. RIP3, a novel apoptosis-inducing kinase.
    J Biol Chem. 1999 Jun 11;274(24):16871-5 PMID: 10358032
  34. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.
    Mol Cell Biol. 1999 Aug;19(8):5785-99 PMID: 10409765
  35. The molecular regulation of myogenesis.
    Clin Genet. 2000 Jan;57(1):16-25 PMID: 10733231
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2002-08-00
Pages
5879-86
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC133983
Subset
IM
Grants
NIA NIH HHS · R37 AG009521 · United States
NIA NIH HHS · AG09521 · United States
NHLBI NIH HHS · HL65572 · United States
NHLBI NIH HHS · R01 HL065572 · United States
NICHD NIH HHS · HD18179 · United States
NCI NIH HHS · CA59717 · United States
NIA NIH HHS · R01 AG009521 · United States
NICHD NIH HHS · R01 HD018179 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com